NextCell Pharma ABNXTCL 
$0.16-2.40%24h
-2.40%24h
Global rank34314
Market cap$5.49M
Change 7d21.64%
YTD Performance-38.02%
SP500 benchmarkUnderperform
P/E-0.14
P/S5.54
Revenue$990.69K
Earnings-$3.90M
Dividend yield-
Main Sector
Healthcare
Category
NextCell Pharma AB (NXTCL) Total Liabilities
NXTCL Total Liabilities in 2022: $1.28M
According to NextCell Pharma AB latest financial reports the total liabilities of NXTCL is $1.28M, an increase of 43.70% to 2022. At the end of 2022 company had $893.03K total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that NextCell Pharma AB is responsible for during its operational activities.
NextCell Pharma AB (NXTCL) Total Liabilities History from 2023 to 2022
-
Value:-
NXTCL Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $1.28M | 43.70% |
| 2022 | $893.03K | 64.75% |
| 2021 | $542.04K | 55.62% |
| 2020 | $348.30K | -5.37% |
| 2019 | $368.05K | 120.70% |
| 2018 | $166.77K | - |
View the Top Total Liabilies Stocks
